Chalandri, Attica, Greece, 26th May 2026 —   EmBIO Medical Center, an IVF and reproductive healthcare centre in Greece, has released new educational information highlighting the role of estradiol in female fertility and reproductive health.

Estradiol is one of the primary hormones involved in regulating the menstrual cycle and supporting egg development. It also helps prepare the body for pregnancy, making it an important factor in overall fertility health.

Through this latest educational release, EmBIO Medical Center aims to help patients better understand how hormonal balance can influence fertility and reproductive wellbeing. The centre continues to provide guidance and support for individuals and couples seeking answers about fertility-related concerns.

The clinic also highlighted the importance of regular medical evaluation when addressing hormonal or fertility-related issues. Understanding hormone levels can help patients make informed decisions about their reproductive health and treatment options. Educational resources shared by the centre are intended to encourage open conversations between patients and fertility specialists.

As part of its ongoing commitment to patient education, EmBIO Medical Center – IVF in Greece continues to share information designed to help patients better understand different aspects of fertility and reproductive care.

The clinic encourages anyone with questions about estradiol, fertility, or reproductive treatment options to contact its medical team for further information and personalised support.

About EmBIO Medical Center
EmBIO Medical Center is a leading fertility and reproductive healthcare centre based in Athens, specialising in IVF and advanced fertility treatments. The centre provides personalised care and supports individuals and couples throughout their journey to parenthood.

Media Contact

Organization: EmBIO Medical Center

Contact Person: EmBIO Medical Center

Website: https://www.ivf-embryo.gr

Email: Send Email

City: Chalandri

State: Attica

Country:Greece

Release id:45429

The post EmBIO Medical Center Releases Educational Overview on Estradiol and Female Fertility appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

Nicosia, Cyprus, 26th May 2026 – Cyprus IVF Centre, a leading fertility clinic in Nicosia, has highlighted the integration of advanced IVF witness technology within its embryology laboratory, reinforcing safety, accuracy, and traceability throughout fertility treatment procedures.

As demand continues to grow for north cyprus IVF treatment options among international patients, the clinic continues to strengthen its laboratory systems and quality control processes to support safe and efficient fertility care.

The IVF Witness System provides electronic tracking and verification of eggs, sperm, and embryos during key stages of the IVF process. The technology is designed to support secure sample identification and help minimise the risk of human error throughout treatment.

The system operates across multiple stages of the embryology workflow, including fertilisation, embryo culture, cryopreservation, and embryo transfer preparation. Each step is digitally monitored to help maintain consistent laboratory control and oversight.

The introduction of advanced witness technology reflects the increasing adoption of digital monitoring systems across modern reproductive medicine laboratories. By combining laboratory automation with experienced embryology care, Cyprus IVF Centre continues to strengthen its commitment to high-quality fertility treatment for both local and international patients seeking North Cyprus IVF services.

The clinic continues to invest in advanced reproductive technologies and personalised fertility care for patients travelling from the United Kingdom, Europe, and other international locations.

“Your IVF journey is built on trust, and every detail matters,” the clinic stated in a recent social media announcement highlighting the IVF Witness System and its role in supporting greater confidence and peace of mind during treatment.

About Cyprus IVF Centre

Cyprus IVF Centre is a fertility clinic based in Nicosia offering IVF treatment, donor programmes, fertility preservation, and advanced reproductive technologies for local and international patients.

Media Contact

Organization: Team Miracle – Cyprus IVF Centre

Contact Person: Team Miracle – Cyprus IVF Centre

Website: https://cyprusivfcentre.com/

Email: Send Email

City: Nicosia

Country:Cyprus

Release id:45425

The post Cyprus IVF Centre Strengthens High Standards in Embryology Through Advanced Witness Systems appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

The quantum-native Web3 foundation is building a multilingual newsroom for quantum science, post-quantum security, and the quantum threat to digital assets. Modeled on the global playbook of Pokernews.com and Cryptonews.com.

Panama, 26th May 2026 – The quantum-native Web3 foundation, qLABS, today announced the launch of a global, multilingual media, content, and research platform dedicated to quantum computing and its impact on finance, security, and digital assets. The platform will serve as qLABS’ editorial and research arm, with an official site launch planned for later in 2026.

The initiative is led by qLABS President Antanas Guoga (“Tony G”), whose track record in building category-defining digital media properties includes Pokernews.com and Cryptonews.com. The new platform will apply the same global, multilingual operating model to a category that, in qLABS’ view, still lacks credible, technically rigorous coverage at retail scale.

Coverage areas at launch will include:

●      Quantum hardware and scientific breakthroughs, with primary-source explainers for non-specialist audiences.

●      The investability of the quantum sector, including public quantum equities and quantum-adjacent infrastructure.

●      The quantum threat to fintech, payments rails, and digital assets, including ongoing analysis of post-quantum cryptography standardization at NIST and parallel work at chain foundations.

●      Industry news, hiring moves, policy and procurement developments (NSA CNSA 2.0, EU NIS2, U.S. federal PQC migration mandates).

●      Original research, including qLABS’ L1 Quantum Vulnerability Index (qLVI) and the Quantum-Vulnerable Capital series.

Antanas Guoga (“Tony G”), President, qLABS: “This will be no smaller revolution than Bitcoin. I have been actively following the industry for a few years now and see major opportunities arising. qLABS aims to get actively involved in education, media and research on quantum-related topics.”

qLABS also confirmed the upcoming retail launch of qVAULT, a quantum-safe vault for crypto built for end-user custody. qVAULT is in active discussions with a number of corporate users, with institutional partner names to be disclosed in subsequent releases. qVAULT is powered by qONE, qLABS’ quantum-resistant token deployed on Hyperliquid.

qLABS’ published research finds that, as of May 9, 2026, none of the top 20 Layer-1 blockchains by market capitalization have shipped live post-quantum signatures in production, leaving approximately $2.25 trillion in top-20 L1 capital exposed under a harvest-now, decrypt-later threat model. Of that base, 91.7% sits on chains with active post-quantum research and development underway, 2.6% on chains with stated intent only, and 5.7% on chains with no published PQC roadmap. The accompanying L1 Quantum Vulnerability Index (qLVI) ranks the top 10 blockchains on quantum readiness. Both research products will be republished and updated on a quarterly cadence through the new media platform.

Learn more at: https://qlabs.tech/

For inquiries contact gintautas@qlabs.tech

About qLABS

qLABS is a quantum-native Web3 foundation focused on post-quantum security for digital assets. The foundation operates qONE, its quantum-resistant native token deployed on Hyperliquid; qVAULT, an upcoming retail-focused quantum-safe crypto vault; and a published research program covering blockchain quantum vulnerability and the quantum-vulnerable capital base across the largest Layer-1 networks. qLABS is backed by 01 Quantum Inc. (TSXV: ONE; OTCQB: OONEF).

Media Contact

Organization: qLABS

Contact Person: Ada Jonuse

Website: https://qlabs.tech/

Email: Send Email

Country:Panama

Release id:45424

Disclaimer: This press release is provided for informational purposes only. It does not constitute investment, financial, legal, or regulatory advice, nor should it be relied upon for decision-making.

The post Global Media, Content and Research Platform Launched by qLABS for the Quantum Era appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section